Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy
Hailey Hill, Myra Robinson, Lauren Xiaoyuan Lu, Daniel Slaughter, Asim Amin, Kathryn F. Mileham, Jai N. Patel
Topics & Concepts
MedicineInternal medicineOncologyLung cancerAtezolizumabPerformance statusPembrolizumabNivolumabChemotherapyCancerImmunotherapyVenous Thromboembolism Diagnosis and ManagementCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease Prognosis